Skip to main content

Test Price

900 AED

โœ… Home Collection Available

ROS1 Immunohistochemistry (IHC) Test in UAE | 900 AED | DHA Guidelines

Our DHA-accredited medical center offers the ROS1 Immunohistochemistry (IHC) test with 99.9% diagnostic sensitivity via ISO-certified laboratories. Specimen handling follows strict protocols for solid tissue retrieval via secure medical courier. Post-test telephonic clinical guidance is provided for result interpretation. Direct billing verification is available via WhatsApp +971 54 548 8731.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
  • Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Executive Summary & Core Metrics

The ROS1 Immunohistochemistry (IHC) Test is a specialized laboratory assay that detects ROS1 protein overexpression in formalin-fixed paraffin-embedded (FFPE) tumor tissue, primarily to identify patients with non-small cell lung cancer (NSCLC) who may benefit from targeted therapy with crizotinib or entrectinib. This test uses monoclonal antibody D4D6 immunostaining and follows DHA guidelines for precision oncology.

Test Overview & Methodology

This assay employs validated immunohistochemical staining techniques on FFPE tissue sections. The monoclonal antibody D4D6 targets the ROS1 protein, with results interpreted by board-certified pathologists. Sensitivity and specificity are optimized for NSCLC screening.

Feature Our ROS1 IHC Test Closest Alternative (FISH)
Methodology Immunohistochemistry (Monoclonal Antibody D4D6) Fluorescence In Situ Hybridization (Break-Apart Probe)
Sensitivity 95% (screening) 98%
Specificity 100% 100%
Turnaround Time 5 working days (block), 7 days (large tissue) 7โ€“10 working days
Sample Requirement FFPE block or tumor tissue in 10% formal-saline FFPE block or fresh tissue
Accreditation ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) & DHA Licensed Variable

Physician Insight & Safety Protocols

"ROS1 IHC serves as an effective screening tool for identifying potential candidates for targeted therapy. However, confirmatory testing via FISH or NGS is essential before initiating treatment. Our diagnostic pathway ensures accurate classification and guides oncologists in making informed therapeutic decisions."

โ€” Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

โš ๏ธ Important Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

Safety Information

Exclusion Criteria

  • Absence of a complete histopathology report
  • Insufficient tumor tissue or non-viable sample
  • Sample not submitted in formalin or FFPE block
  • Unaccompanied clinical history or biopsy site information

Emergency Red Flags

  • Sudden worsening of respiratory distress or shortness of breath
  • Acute severe pain or hemoptysis
  • Signs of neurological deterioration (confusion, loss of consciousness)
  • Any other severe symptom requiring immediate medical attention

Patient FAQ & Clinical Guidance

1. What is the ROS1 IHC test used for?

Answer: The ROS1 IHC test detects ROS1 protein in tumor tissue, aiding precision lung cancer treatment decisions. It is primarily used in non-small cell lung cancer to screen for ROS1 rearrangements. A positive result suggests eligibility for targeted therapies such as crizotinib, but confirmation by FISH or NGS is strongly advised. The test requires a formalin-fixed paraffin-embedded (FFPE) tumor sample and your clinical history.

2. How do I prepare for the ROS1 IHC test?

Answer: No dietary restrictions, medication changes, or fasting are required. Simply bring your doctorโ€™s referral, the original histopathology report, and details of the biopsy location. Our specimen logistics team will handle the secure courier transport for the FFPE block or tissue sample.

3. When will I receive my ROS1 IHC results?

Answer: Turnaround time varies by sample type: 5 working days for standard FFPE blocks, 7 working days for large or complex tissue specimens. Reports are securely delivered electronically and include a telephonic consultation for result explanation.

UAE Regulatory & Data Privacy Adherence

Data Privacy and Health Information Compliance

DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data and test results are handled with strict confidentiality and security protocols. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name ROS1 Immunohistochemistry (IHC) Test
Price (AED) 900 AED
Turnaround Time 5โ€“7 working days depending on sample type
Sample Type / Matrix FFPE block or tumor tissue in 10% formal-saline
Methodology Used Immunohistochemistry (Monoclonal Antibody D4D6)
ICD-10-CM Code C34.90 (Malignant neoplasm of unspecified part of unspecified bronchus or lung)
LOINC Code 19049-2 (ROS1 gene rearrangement in tissue by IHC)
DHA Facility License & Address License #1143 โ€“ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ€“ DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians